
Currently out of the existing stock ratings of Michael Petusky, 363 are a BUY (89.85%), 39 are a HOLD (9.65%), 2 are a SELL (0.5%).
Analyst Michael Petusky, currently employed at BARRINGTON, has had 60.01% of price targets met with an average potential upside of 26.68%, reached in 254 days on average.
Michael Petusky has documented 768 price targets and ratings displayed on 23 stocks. The coverage is on Healthcare, Consumer Defensive, Technology, Utilities sectors.
Most recent stock forecast was given on USPH, US Physicalrapy.
Analyst best performing recommendations are on BVS (BIOVENTUS).
The best stock recommendation documented was for ANIK (ANIKA THERAPEUTICS) on 11/9/2022. The price target of $31 was fulfilled within 1 day with a profit of $1.4 (4.73%), with a performance score of 47.3.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Jul-2025
$21
$7.6 (56.72%)
$16
3 months 18 days ago
(30-Jul-2026)
2/2 (100%)
$2.93 (16.21%)
134
Buy Since 03-Nov-2023
$17
$3.6 (26.87%)
$16
8 months 21 days ago
(27-Feb-2026)
17/22 (77.27%)
$2.64 (18.38%)
172
Hold Since 14-Oct-2022
$24
$23
2 years 5 months 19 days ago
(29-May-2024)
5/5 (100%)
$-1.64 (-6.40%)
129
Buy Since 09-Aug-2023
$32
3 years 3 months 8 days ago
(09-Aug-2023)
1/2 (50%)
$11.99 (59.92%)
73
Buy Since 15-Nov-2021
$35
$55
4 years 8 months 8 days ago
(09-Mar-2022)
0/2 (0%)
$8.78 (33.49%)
Which stock is Michael Petusky most bullish on?
Which stock is Michael Petusky most reserved on?
What Year was the first public recommendation made by Michael Petusky?